Tango Therapeutics Inc.
TNGX | NASDAQ
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$21.80
-$0.53 (-2.37%)
Pre-market:
Sep 22, 2026, 9:11 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -123.72M | -107.23M | -101.59M | -100.52M | -145.57M | -132.26M | -130.3M | -123.4M | -116.49M | -111.65M | -101.74M | -100.04M | -106.83M | -110.98M | -108.18M | -101.16M | -91.7M | -71.34M | -58.24M | -45.05M | -52.27M | -56.16M |
Depreciation & Amortization | 1.92M | 2.12M | 2.28M | 2.42M | 2.49M | 2.5M | 2.5M | 2.5M | 2.49M | 2.46M | 2.42M | 2.37M | 2.17M | 1.88M | 1.61M | 1.29M | 1.1M | 1M | 897K | 832K | 793K | 758K |
Stock-Based Compensation | 40.29M | 29.97M | 26.43M | 27.91M | 28.47M | 29.43M | 28.9M | 26.31M | 24M | 21.58M | 19.08M | 17.99M | 16.94M | 15.24M | 14.23M | 12.7M | 12.32M | 10.09M | 7.83M | 6.11M | 3.1M | 2.31M |
Other Working Capital | -62.39M | -66.56M | -66.37M | -74.65M | -35.39M | -34.34M | -30.56M | -26.58M | -25.82M | -30.9M | -38.26M | -40.54M | -26.35M | -26.8M | -19.59M | -20.79M | -24.91M | -21.09M | -18.58M | -22.94M | -17.19M | -10.87M |
Other Non-Cash Items | 544K | 815K | 1.2M | 1.11M | 456K | -75K | -849K | -2.39M | -470K | -210K | 234K | 2.1M | 1.01M | 1.32M | 1.75M | 1.74M | 1.46M | 1.44M | 1.32M | 1.25M | 136.63M | 131.74M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -62.94M | -67.23M | -67.2M | -76.75M | -34.1M | -34.93M | -31.75M | -25.35M | -29.59M | -33.11M | -37.97M | -41.19M | -20.55M | -21.79M | -18.49M | -12.29M | -22.78M | -16.77M | -11.35M | -23.82M | -16.19M | -10.05M |
Operating Cash Flow | -143.9M | -141.55M | -138.89M | -145.82M | -148.25M | -135.34M | -131.5M | -122.32M | -120.07M | -120.93M | -117.98M | -118.78M | -107.26M | -114.32M | -109.08M | -97.72M | -99.6M | -75.58M | -59.53M | -60.69M | 72.07M | 68.59M |
Capital Expenditures | -373K | -997K | -1.05M | -950K | -914K | -610K | -754K | -856K | -757K | -1.1M | -1.53M | -2.34M | -5.6M | -6.75M | -7.69M | -7.35M | -4.84M | -3.23M | -1.84M | -1.6M | -955K | -1.24M |
Cash Acquisitions | 22K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -766.86M | -271.71M | -264.46M | -121.99M | -143.11M | -167.79M | -240.89M | -259.36M | -376.14M | -378.3M | -310.57M | -353.11M | -241.32M | -206.47M | -208.5M | -219.33M | -356.74M | -407.06M | -372.36M | -373.57M | -191.71M | -125.47M |
Sales Maturities Of Investments | 242.64M | 210.87M | 224.64M | 269.85M | 276.03M | 296.33M | 327.77M | 328.14M | 355.58M | 378.08M | 353.53M | 350.42M | 313.79M | 282.89M | 242.6M | 220.48M | 187.93M | 194.53M | 190.76M | 177.77M | 147.35M | 87.53M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40K | -69.66M | -97.56M |
Investing Cash Flow | -524.58M | -61.83M | -40.87M | 146.91M | 132.01M | 127.93M | 86.13M | 67.92M | -21.32M | -1.33M | 41.43M | -5.03M | 66.86M | 69.67M | 26.4M | -6.2M | -173.65M | -215.76M | -183.43M | -197.44M | -114.97M | -136.74M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -668K | -573K | -34K | 971K | 3.37M | 4.68M | 5.94M | 6.44M | 4.48M | 3.75M | 2.57M | 1.63M | 1.3M | 1.43M | 1.62M | 968K | 328.64M | 327.18M | 327.34M | 327.48M | 50.79M | 81.39M |
Financial Cash Flow | 974.33M | 302.34M | 222.5M | 4.09M | 3.95M | 4.68M | 47.66M | 48.16M | 126.04M | 125.32M | 82.41M | 81.47M | 1.3M | 1.43M | 1.62M | 968K | 328.64M | 327.17M | 357.33M | 357.38M | 80.69M | 111.3M |
Net Cash Flow | 305.86M | 98.97M | 42.75M | 5.19M | -12.29M | -2.73M | 2.29M | -6.24M | -15.34M | 3.06M | 5.85M | -42.35M | -39.1M | -43.22M | -81.07M | -102.95M | 55.39M | 35.83M | 114.36M | 99.26M | 37.78M | 43.14M |
Free Cash Flow | -144.27M | -142.55M | -139.93M | -146.77M | -149.17M | -135.95M | -132.26M | -123.18M | -120.82M | -122.03M | -119.51M | -121.12M | -112.86M | -121.07M | -116.77M | -105.06M | -104.44M | -78.81M | -61.36M | -62.28M | 71.11M | 67.35M |
Adj. Free Cash Flow | -184.56M | -172.52M | -166.36M | -174.68M | -177.63M | -165.38M | -161.15M | -149.49M | -144.82M | -143.61M | -138.59M | -139.11M | -129.8M | -136.32M | -131M | -117.77M | -116.76M | -88.9M | -69.2M | -68.39M | 68.02M | 65.04M |
Maintenance CapEx | -222K | -846K | -897K | -799K | -799K | -175K | -124K | -226K | -226K | -226K | -837.41K | -1.01M | -4.17M | -5.98M | -6.93M | -7.22M | -4.07M | -2.26M | -696K | -456K | -588K | -1.08M |
Growth CapEx | -151K | -151K | -151K | -151K | -115K | -435K | -630K | -630K | -531K | -875K | -688.59K | -1.33M | -1.44M | -773.14K | -764.55K | -122.81K | -774K | -976K | -1.14M | -1.14M | -367K | -165K |
Owner Earnings | -144.12M | -142.4M | -139.78M | -146.61M | -149.05M | -135.52M | -131.63M | -122.55M | -120.29M | -121.16M | -118.82M | -119.79M | -111.42M | -120.3M | -116.01M | -104.94M | -103.67M | -77.84M | -60.22M | -61.14M | 71.48M | 67.51M |
Add to Watchlist
Select watchlists to add or remove TNGX